Ezetimibe and Simvastatin

Amneal Pharmaceuticals NY LLC🇺🇸 United States

FDA Page

Effective Date: Jan 28, 2022
Approval ID: e515c269-0b34-4cca-970d-2efc7f7a15eb
Products: 4 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EZETIMIBE AND SIMVASTATIN TABLETS safely and effectively. See full prescribing information for EZETIMIBE AND SIMVASTATIN TABLETS. EZETIMIBE and SIMVASTATIN tablets, for oral useInitial U.S. Approval: 2004

Quick Stats

Total Products4

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.